A team led by Wayne State University School of Medicine researcher Mark Greenwald, Ph.D., will use a four-year, $2,279,723 competitively renewed grant from the National Institute on Drug Abuse of the National Institutes of Health to explore whether the opioid addiction treatment medication buprenorphine can decrease the magnitude and/or duration of responses to stressors faced by recovering addicts.
This is the first quantitative study of business manager encounters with drug use which suggests overdose recognition and naloxone training, combined with the operation of supervised injection facilities, could save lives.
Adults over the age of 25 increased their use of marijuana after their home states made changes to medical marijuana laws, according to new research by scientists at Columbia University's Mailman School of Public Health. However, there was no difference in the prevalence of marijuana use reported for 12 to 17 or 18 to 25-year-olds after the laws passed.
Exercise coupled with a regimen of methamphetamine could help addicts get clean, according to a pre-clinical study published today in The FASEB Journal. The reason lies in the mechanism through which exercise and methamphetamine affect circadian rhythms, the roughly 24-hour cycles that drive all organisms.
RTI International, in partnership with the University of Kentucky, has been awarded funding from the National Institute on Drug Abuse and the Appalachian Regional Commission to explore how Appalachian states are addressing the opioid crisis in their communities with the intent of developing evidence-based recommendations for improving services and policies.
One particular protein is the final executioner of events that result in the death of brain cells during stroke, researchers from UT Southwestern Medical Center and their collaborators report.
A new therapeutic target for the treatment of compulsive binge eating has been identified by researchers at Boston University School of Medicine (BUSM).
A person's genetic risk for psychiatric disorders is related to his or her vulnerability to substance use and misuse.
Despite their different triggers, the same molecular chain of events appears to be responsible for brain cell death from strokes, injuries and even such neurodegenerative diseases as Alzheimer's. Now, researchers at Johns Hopkins say they have pinpointed the protein at the end of that chain of events, one that delivers the fatal strike by carving up a cell's DNA. The find, they say, potentially opens up a new avenue for the development of drugs to prevent, stop or weaken the process.
A new national study shows for the first time how smoking bans in cities, states and counties led young people living in those areas to give up, or never take up, the use of cigarettes.